Methods of preparing crosslinked materials and bioprosthetic devices
Methods for making crosslinked material, such as collagen-based material, and bioprosthetic devices. The crosslinked material includes hydroxyl groups, carboxyl groups, and amine groups prior to crosslinking. The methods include removing at least a portion of the zero-length ester crosslinks in a crosslinked material and/or blocking at least a portion of the amine groups that are reactive with carboxyl groups and form zero-length crosslinks.
1. A method for making a crosslinked material, the method comprising:
providing a crosslinked material having zero-length ester crosslinks and spacer crosslinks, wherein the material included amine groups, carboxyl groups, and hydroxyl groups prior to crosslinking;
removing at least a portion of the zero-length ester crosslinks from the crosslinked material.
2. The method of claim 1 wherein the crosslinked material is a crosslinked collagen-based material.
3. The method of claim 2 wherein the collagen-based material comprises whole tissue.
4. The method of claim 1 wherein at least 50% of the zero-length crosslinks are removed.
5. The method of claim 1 wherein removing at least a portion of the zero-length ester crosslinks comprises exposing the crosslinked material to hydrolyzing conditions.
6. The method of claim 5 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to an initial temperature of 4° C. to 40° C.
7. The method of claim 5 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to an initial pH of 2 to 11.
8. The method of claim 7 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to a buffered solution having a pH of 2 to 11.
9. The method of claim 5 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to an acidic buffered solution.
10. The method of claim 5 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to a basic buffered solution.
11. The method of claim 1 wherein removing at least a portion of the zero-length ester crosslinks comprises exposing the crosslinked material to an enzyme.
12. A method for crosslinking collagen-based material, the method comprising:
providing a collagen-based material having collagen amine groups, collagen carboxyl groups, and collagen hydroxyl groups;
blocking at least a portion of the collagen amine groups with a blocking agent to form blocked amine groups;
activating at least a portion of the collagen carboxyl groups after forming blocked amine groups to form activated carboxyl groups;
contacting the activated carboxyl groups with a polyfunctional spacer to crosslink the collagen-based material to form a crosslinked collagen-based material comprising spacer crosslinks and zero-length ester crosslinks; and
removing at least a portion of the zero-length ester crosslinks from the crosslinked collagen-based material.
13. The method of claim 12 wherein blocking at least a portion of the collagen amine groups with a blocking agent to form blocked amine groups comprises contacting at least a portion of the collagen amine groups with a blocking agent selected from the group consisting of an acylating agent, an aminating agent, a biologically active derivative thereof, and mixtures thereof.
14. The method of claim 12 wherein activating at least a portion of the collagen carboxyl groups to form activated carboxyl groups comprises contacting at least a portion of the collagen carboxyl groups with an activating agent selected from the group consisting of a carbodiimide, an azide, 1,1′-carbonyldiimidazole, N,N′-disuccinimidyl carbonate, 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline, 1,2-benzisoxazol-3-yl-diphenyl phosphate, and N-ethyl-5-phenylisoxazolium-s′-sulfonate, and mixtures thereof.
15. The method of claim 14 wherein the activating agent is a carbodiimide.
16. The method of claim 12 wherein activating at least a portion of the collagen carboxyl groups to form activated carboxyl groups comprises contacting at least a portion of the collagen carboxyl groups with an activating agent in the presence of a stabilizing agent.
17. The method of claim 12 wherein the polyfunctional spacer is a diamine spacer.
18. The method of claim 12 wherein the collagen-based material comprises whole tissue.
19. The method of claim 12 wherein at least 50% of the zero-length crosslinks are removed.
20. The method of claim 12 wherein removing at least a portion of the zero-length ester crosslinks comprises exposing the crosslinked material to hydrolyzing conditions.
21. The method of claim 20 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to an initial temperature of 4° C. to 40° C.
22. The method of claim 20 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to an initial pH of 2 to 11.
23. The method of claim 20 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to a buffered solution having a pH of 2 to 11.
24. The method of claim 20 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to an acidic buffered solution.
25. The method of claim 20 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to a basic buffered solution.
26. The method of claim 12 wherein removing at least a portion of the zero-length ester crosslinks comprises, exposing the crosslinked material to an enzyme.
27. A method for crosslinking material, the method comprising:
providing a material having amine groups, carboxyl groups, and hydroxyl groups;
blocking at least a portion of the amine groups with a blocking agent to form blocked amine groups;
activating at least a portion of the carboxyl groups after forming blocked amine groups to form activated carboxyl groups;
contacting the activated carboxyl groups with a polyfunctional spacer to crosslink the material to form a crosslinked material comprising spacer crosslinks and zero-length ester crosslinks; and
removing at least a portion of the zero-length ester crosslinks from the crosslinked material.
28. The method of claim 27 wherein blocking at least a portion of the amine groups with a blocking agent to form blocked amine groups comprises contacting at least a portion of We amine groups with a blocking agent selected from the group consisting of an acylating agent, aminating agent, a biologically active derivative thereof, and mixtures thereof.
29. The method of claim 27 wherein activating at least a portion of the carboxyl groups to form activated carboxyl groups comprises contacting at least a portion of the carboxyl groups with an activating agent selected from the group consisting of a carbodiimide, an azide, 1,1′-carbonyldiimidazole, N,N′-disuccinimidyl carbonate, 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline, 1,2-benzisoxazol-3-yl-diphenyl phosphate, and N-ethyl-5-phenylisoxazolium-s′-sulfonate and mixtures thereof.
30. The method of claim 27 wherein activating at least a portion of the carboxyl groups to form activated carboxyl groups comprises contacting at least a portion of the carboxyl groups with an activating agent in the presence of a stabilizing agent.
31. The method of claim 27 wherein the polyfunctional spacer is a diamine spacer.
32. The method of claim 27 wherein removing at least a portion of the zero-length ester crosslinks comprises exposing the crosslinked material to hydrolyzing conditions.
33. The method of claim 32 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to an initial temperature of 4° C. to 40° C. and an initial pH of 2 to 11.
34. The method of claim 32 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to an acidic buffered solution.
35. The method of claim 32 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to a basic buffered solution.
36. The method of claim 27 wherein removing at least a portion of the zero-length ester crosslinks comprises exposing the crosslinked material to an enzyme.
37. A method for making a bioprosthetic device, the method comprising:
providing a crosslinked collagen-based material having zero-length ester crosslinks and spacer crosslinks, wherein the collagen-based material included collagen amine groups, collagen carboxyl groups, and collagen hydroxyl groups prior to crosslinking; and
removing at least a portion of the zero-length ester crosslinks from the crosslinked collagen-based material.
38. The method of claim 37 wherein the bioprosthetic device is a heart valve.
39. The method of claim 37 wherein the collagen-based material comprises whole tissue.
40. The method of claim 37 wherein at least 50% of the zero-length ester crosslinks are removed.
41. The method of claim 37 wherein removing at least a portion of the zero-length ester crosslinks comprises exposing the collagen-based crosslinked material to hydrolyzing conditions.
42. The method of claim 41 wherein exposing the crosslinked collagen-based material to hydrolyzing conditions comprises exposing the crosslinked collagen-based material to an initial temperature of 4° C. to 40° C.
43. The method of claim 41 wherein exposing the crosslinked collagen-based material to hydrolyzing conditions comprises exposing the crosslinked collagen-based material to an initial pH of 2 to 11.
44. The method of claim 41 wherein exposing the crosslinked collagen-based material to hydrolyzing conditions comprises exposing the crosslinked collagen-based material to a buffered solution having a pH of 2 to 11.
45. The method of claim 41 wherein exposing the crosslinked collagen-based material to hydrolyzing conditions comprises exposing the crosslinked collagen-based material to an acidic buffered solution.
46. The method of claim 41 wherein exposing the crosslinked collagen-based material to hydrolyzing conditions comprises exposing the crosslinked collagen-based material to a basic buffered solution.
47. The method of claim 37 wherein removing at least a portion of the zero-length ester crosslinks comprises exposing the crosslinked collagen-based material to an enzyme.
48. A method for making a bioprosthetic device, the method comprising:
providing a collagen-based material having collagen amine groups, collagen carboxyl groups, and collagen hydroxyl groups;
blocking at least a portion of the collagen amine groups with a blocking agent to form blocked amine groups;
activating at least a portion of the collagen carboxyl groups after forming blocked amine groups and blocked hydroxyl groups to form activated carboxyl groups;
contacting the activated carboxyl groups with a polyfunctional spacer to crosslink the collagen-based material to form a crosslinked collagen-based material comprising spacer crosslinks and zero-length ester crosslinks; and
removing at least a portion of the zero-length ester crosslinks from the crosslinked material.
49. The method of claim 48 wherein the collagen-based material comprises whole tissue.
50. The method of claim 48 wherein blocking at least a portion of the amine groups with a blocking agent to form blocked amine groups comprises contacting at least a portion of the amine groups with a blocking agent selected from the group consisting of an acylating agent, an aminating agent, a biologically active derivative thereof, and mixtures thereof.
51. The method of claim 48 wherein activating at least a portion of the carboxyl groups to form activated carboxyl groups comprises contacting at least a portion of the carboxyl groups with an activating agent selected from the group consisting of a carbodiimide, an azide, 1,1′-carbonyldiimidazole, N,N′-disuccinimidyl carbonate, 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline, 1,2-benzisoxazol-3-yl-diphenyl phosphate, and N-ethyl-5-phenylisoxazolium-s′-sulfonate and mixtures thereof.
52. The method of claim 48 wherein activating at least a portion of the carboxyl groups to form activated carboxyl groups comprises contacting at least a portion of the carboxyl groups with an activating agent in the presence of a stabilizing agent.
53. The method of claim 48 wherein the polyfunctional spacer is a diamine spacer.
54. The method of claim 48 wherein removing at least a portion of the zero-length ester crosslinks comprises exposing the crosslinked material to hydrolyzing conditions.
55. The method of claim 54 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to an initial temperature of 4° C. to 40° C. and an initial pH of 2 to 11.
56. The method of claim 54 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to an acidic buffered solution.
57. The method of claim 54 wherein exposing the crosslinked material to hydrolyzing conditions comprises exposing the crosslinked material to a basic buffered solution.
58. The method of claim 48 wherein removing at least a portion of the zero-length ester crosslinks comprises exposing the crosslinked material to an enzyme.
59. A bioprosthetic device preparable by the method of claim 37 .
60. A bioprosthetic device preparable by the method of claim 48 .